Naoki Furuya

Ohio State University

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (8)

Terufumi Kato

Chief Physician

Kanagawa Cancer Center

Masamichi Mineshita

Tateaki Naito

Clinical Professor

St. Luke's International University

Joshua Reuss

Assistant Professor of Medicine

UNITED STATES

Eisaku Miyauchi

Assistant Professor

Tohoku Daigaku

Tatsuki Ikoma

Kobe University Hospital

Kadoaki Ohashi

Okayama University Hospital

Ana I Velazquez

Assistant Professor

University of California, San Francisco

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Naoki Furuya

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (8)

Terufumi Kato

Masamichi Mineshita

Tateaki Naito

Joshua Reuss

Eisaku Miyauchi

Tatsuki Ikoma

Kadoaki Ohashi

Ana I Velazquez

Make your next move.

Naoki Furuya

Research Interests

Explore related searches

Contact this professor

Articles (20)

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1

Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer

EGFR Exon 20 insertions in NSCLC: from biology to amivantamab, optimal treatment strategy and emerging therapeutics

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression

YAP Regulates HER3 Signaling–Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers

Exploration of clinical Biomarkers for guiding treatment selection between chemotherapy and combination therapy with Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Mutant NSCLC patients after EGFR-TKI Therapy: The SPIRAL-STEP study

Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients

Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study

Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630

Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?

Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study).

Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.

Nivolumab retreatment in non-small cell lung cancer patients who responded to prior immune-checkpoint inhibitors and had ICI-free intervals (WJOG9616L).

A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study

Solid histological component of adenocarcinoma might play an important role in PD‐L1 expression of lung adenocarcinoma

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Collaborators (8)

Terufumi Kato

Masamichi Mineshita

Tateaki Naito

Joshua Reuss

Eisaku Miyauchi

Tatsuki Ikoma

Kadoaki Ohashi

Ana I Velazquez

Make your next move.